Clinical Profile and Therapeutic Management of Patients with Atrial Fibrillation in Greece: Results from the Registry of Atrial Fibrillation to Investigate New Guidelines (RAFTING)

被引:0
作者
Farmakis, Dimitrios [1 ,2 ]
Pipilis, Athanasios [3 ]
Antoniou, Anna [4 ]
Kaliambakos, Sotirios [3 ]
Goudevenos, John [5 ]
Anastasiou-Nana, Maria [2 ]
Pyrgakis, Vlassios [6 ]
Parcharidis, Georgios [7 ]
Lekakis, John [2 ]
机构
[1] Univ Athens, Dept Internal Med 1, Sch Med, Laiko Hosp, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Dept Cardiol 2, Attikon Univ Hosp, GR-11527 Athens, Greece
[3] Hygeia Hosp, Dept Cardiol 1, Athens, Greece
[4] Univ Athens, Dept Therapeut, Sch Med, Alexandra Hosp, GR-11527 Athens, Greece
[5] Univ Ioannina, Sch Med, Ioannina Univ Hosp, Dept Cardiol, GR-45110 Ioannina, Greece
[6] G Gennimatas Gen Hosp, Dept Cardiol, Athens, Greece
[7] Aristotle Univ Thessaloniki, Sch Med, Dept Cardiol 1, AHEPA Univ Hosp, GR-54006 Thessaloniki, Greece
关键词
Atrial fibrillation; atrial flutter; registry; antithrombotic therapy; warfarin; antiplatelets; EURO HEART SURVEY; ORAL ANTICOAGULANTS; TASK-FORCE; STROKE PREVENTION; PERCEPTIONS; PREVALENCE; COUNTRIES; BARRIERS; SOCIETY; BENEFIT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Atrial fibrillation (AF) is the most common arrhythmia with significant morbidity, including a 5-fold increase in stroke risk. The management of AF, including antithrombotic therapy (AT), varies considerably among countries. Representative data concerning AF features and management in Greece are generally lacking. Methods: The Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING) is a country-wide prospective observational study of AF in Greece that enrolled consecutive patients with a diagnosis of AF in emergency departments of 31 hospitals of different types according to the population's geographical distribution. Results: RAFTING enrolled 1127 patients, 51% females, aged 71 +/- 12 years. Paroxysmal AF was present in 54% of patients and newly diagnosed AF in 28%; 68% of patients with a previous AF history had undergone a median of 4 cardioversions. A high rate of comorbidities was present, including arterial hypertension in 75% and heart failure in 40%. The median CHADS(2) and CHA(2)DS(2)VASc scores were 2 and 3, respectively; AT had been prescribed in 87% of non-newly diagnosed patients, with warfarin being prescribed in 56% of them. Among all patients on warfarin, INR values were within therapeutic range in 34% of cases during inhospital measurement. Hospital admission occurred in 82% of cases, with in-hospital mortality 0.8%. Conclusions: RAFTING provides updated insights into the current features and management of AF in Greece. The majority of patients have a sufficiently high risk to warrant oral anticoagulation and further attempts to comply with the existing guidelines are warranted.
引用
收藏
页码:368 / 375
页数:8
相关论文
共 22 条
[1]  
Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
[2]   Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range [J].
Connolly, Stuart J. ;
Pogue, Janice ;
Eikelboom, John ;
Flaker, Gregory ;
Commerford, Patrick ;
Franzosi, Maria Grazia ;
Healey, Jeffrey S. ;
Yusuf, Salim .
CIRCULATION, 2008, 118 (20) :2029-2037
[3]   New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease Position Paper [J].
De Caterina, Raffaele ;
Husted, Steen ;
Wallentin, Lars ;
Andreotti, Felicita ;
Arnesen, Harald ;
Bachmann, Fedor ;
Baigent, Colin ;
Huber, Kurt ;
Jespersen, Jorgen ;
Kristensen, Steen Dalby ;
Lip, Gregory Y. H. ;
Morais, Joao ;
Rasmussen, Lars Hvilsted ;
Siegbahn, Agneta ;
Verheugt, Freek W. A. ;
Weitz, Jeffrey I. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (16) :1413-1425
[4]   Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study [J].
Deplanque, D ;
Leys, D ;
Parnetti, L ;
Schmidt, R ;
Ferro, J ;
De Reuck, J ;
Mas, JL ;
Gallai, V .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (06) :798-806
[5]   ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation -: executive summary -: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [J].
Fuster, Valentin ;
Ryden, Lars E. ;
Cannom, David S. ;
Crijns, Harry J. ;
Curtis, Anne B. ;
Ellenbogen, Kenneth A. ;
Halperin, Jonathan L. ;
Le Heuzey, Jean-Yves ;
Kay, G. Neal ;
Lowe, James E. ;
Olsson, S. Bertil ;
Prystowsky, Eric N. ;
Tamargo, Juan Luis ;
Wann, Samuel ;
Priori, Silvia G. ;
Blanc, Jean-Jacques ;
Budaj, Andrzej ;
Camm, John ;
Dean, Veronica ;
Deckers, Jaap W. ;
Despres, Catherine ;
Dickstein, Kenneth ;
Lekakis, John ;
McGregor, Keith ;
Metra, Marco ;
Morais, Joao ;
Osterspey, Ady ;
Tamargo, Juan Luis ;
Zamorano, Jose Luis ;
Smith, Sidney C. ;
Jacobs, Alice K. ;
Adams, Cynthia D. ;
Anderson, Jeffery L. ;
Antman, Elliott M. ;
Halperin, Jonathan L. ;
Hunt, Sharon Ann ;
Nishimura, Rick ;
Ornato, Joseph P. ;
Page, Richard L. ;
Riegel, Barbara .
EUROPEAN HEART JOURNAL, 2006, 27 (16) :1979-2030
[6]   Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].
Go, AS ;
Hylek, EM ;
Phillips, KA ;
Chang, YC ;
Henault, LE ;
Selby, JV ;
Singer, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2370-2375
[7]   An epidemiological study of symptomatic paroxysmal atrial fibrillation in northwest Greece [J].
Goudevenos, JA ;
Vakalis, JN ;
Giogiakas, V ;
Lathridou, P ;
Katsouras, C ;
Michalis, LK ;
Sideris, DA .
EUROPACE, 1999, 1 (04) :226-233
[8]  
Goudevenos J, 2012, HELL J CARDIOL, V53, P137
[9]   What are the barriers to warfarin use in atrial fibrillation?:: Development of a questionnaire [J].
Ingelgård, A ;
Hollowell, J ;
Reddy, P ;
Gold, K ;
Tran, K ;
Fitzmaurice, D .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2006, 21 (03) :257-265
[10]   Current Perceptions of the Epidemiology of Atrial Fibrillation [J].
Kannel, William B. ;
Benjamin, Emelia J. .
CARDIOLOGY CLINICS, 2009, 27 (01) :13-+